Cargando…
Epigenetics in Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disease with unknown pathogenesis and complex pathological manifestations. At present, a large number of studies on targeted drugs for the typical pathological phenomenon of AD (Aβ) have ended in failure. Although there are some drugs on the market tha...
Autores principales: | Gao, Xiaodie, Chen, Qiang, Yao, Hua, Tan, Jie, Liu, Zheng, Zhou, Yan, Zou, Zhenyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260511/ https://www.ncbi.nlm.nih.gov/pubmed/35813941 http://dx.doi.org/10.3389/fnagi.2022.911635 |
Ejemplares similares
-
Epigenetic regulation of synaptic disorder in Alzheimer’s disease
por: Chen, Zhiying, et al.
Publicado: (2022) -
Epigenetic Alterations in Alzheimer’s Disease
por: Sanchez-Mut, Jose V., et al.
Publicado: (2015) -
Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer’s disease
por: Zhou, Lan-Ting, et al.
Publicado: (2023) -
The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018) -
Pathological and physiological functional cross-talks of α-synuclein and tau in the central nervous system
por: Jin, Mingyue, et al.
Publicado: (2023)